Kazia Therapeutics Files Form 6-K
Ticker: KZIA · Form: 6-K · Filed: Jul 9, 2025 · CIK: 1075880
| Field | Detail |
|---|---|
| Company | Kazia Therapeutics LTD (KZIA) |
| Form Type | 6-K |
| Filed Date | Jul 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
Related Tickers: KZA
TL;DR
Kazia Therapeutics (KZA) filed a routine 6-K, no new info.
AI Summary
Kazia Therapeutics Limited, formerly Novogen Ltd, filed a Form 6-K on July 9, 2025. The company, based in Sydney, NSW, is a foreign private issuer and is submitting this report under the Securities Exchange Act of 1934. This filing does not appear to contain specific financial or operational updates beyond its classification as a periodic report.
Why It Matters
This filing indicates Kazia Therapeutics is meeting its regulatory reporting obligations as a foreign private issuer with the SEC. It does not provide new operational or financial information.
Risk Assessment
Risk Level: low — This is a standard regulatory filing by a foreign private issuer and does not contain new material information that would typically impact risk.
Key Players & Entities
- Kazia Therapeutics Limited (company) — Registrant
- Novogen Ltd (company) — Former company name
- 000-29962 (dollar_amount) — SEC File Number
- 20250709 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of July 2025.
What is Kazia Therapeutics Limited's SEC file number?
Kazia Therapeutics Limited's SEC file number is 000-29962.
When was Kazia Therapeutics Limited previously known as?
Kazia Therapeutics Limited was formerly known as Novogen Ltd, with a date of name change on 19981228.
Where is Kazia Therapeutics Limited's principal executive office located?
Kazia Therapeutics Limited's principal executive office is located at Three International Towers Level 24, 300 Barangaroo Avenue, Sydney NSW 2000.
Does Kazia Therapeutics Limited file its annual reports under Form 20-F or 40-F?
Kazia Therapeutics Limited indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 9, 2025 regarding KAZIA THERAPEUTICS LTD (KZIA).